… of hospitalized patients with coronavirus disease 2019 (COVID-19). … models of coronavirus
diseases, including COVID-19, have … in patients with severe COVID-19 and higher odds of …

… the current status of the COVID-19 (coronavirus disease 2019) … rates of antimicrobial agent
utilisation in COVID-19 patients … of antimicrobials according to the principles of antimicrobial …

… treatment of mild to moderate coronavirus disease (COVID-19). … at risk for complications due
to COVID-19, molnupiravir and … of early COVID-19 in at-risk patients in the outpatient setting. …

… agents for the treatment of COVID-19, antibacterial therapy is being employed in different
ways to combat the disease. For instance, the antimicrobial agents… for COVID-19 management. …

We are publishing a special issue dedicated to the coronavirus, in all its aspects of management
and treatment. Indeed, in the 21st century, it is necessary to share data as quickly as …

… Therefore, based on the available evidence, we recommend not to initiate antimicrobials
routinely in patients admitted to the emergency department or ICU with proven COVID-19. …

… antimicrobial-resistant (AMR) bacterial infections. As we learn more about COVID-19 … to
be a lasting impact of increased use of antimicrobial agents and antibiotics, as well as a lack of …

… creation and maintenance of COVID-19 focused treatment guidelines and the restriction of
potential novel therapeutic agents, including some non-antimicrobial agents. ASPs have also …

… the discovery of novel antimicrobial agents. The recent pandemic … for various antimicrobial,
antiviral, and antifungal agents for … " for drug development for ongoing COVID-19 pandemic. …

… the remaining 10 hospitals that did not admit patients with COVID-19 (MD 6.0 DOT/1000
days-… admitted patients with COVID-19 was observed in broad-spectrum antimicrobial agents. A …